Investigational Drug Information for Norketamine
✉ Email this page to a colleague
What is the drug development status for Norketamine?
Norketamine is an investigational drug.
There have been 11 clinical trials for Norketamine.
The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2018.
The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Pain, Postoperative. The leading clinical trial sponsors are Bhupesh Parashar, MD, Congressionally Directed Medical Research Programs, and Arkansas Children's Hospital Research Institute.
There are twenty-six US patents protecting this investigational drug and one hundred and eight international patents.
Summary for Norketamine
| US Patents | 26 |
| International Patents | 108 |
| US Patent Applications | 131 |
| WIPO Patent Applications | 74 |
| Japanese Patent Applications | 15 |
| Clinical Trial Progress | Phase 1 (2018-08-01) |
| Vendors | 16 |
Recent Clinical Trials for Norketamine
| Title | Sponsor | Phase |
|---|---|---|
| (2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain | Congressionally Directed Medical Research Programs | Phase 1/Phase 2 |
| (2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain | Rush University Medical Center | Phase 1/Phase 2 |
| Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial | Bhupesh Parashar, MD | Phase 2 |
Clinical Trial Summary for Norketamine
Top disease conditions for Norketamine
Top clinical trial sponsors for Norketamine
US Patents for Norketamine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Norketamine | ⤷ Subscribe | Ketamine derivatives | Auckland Uniservices Limited (Auckland, NZ) | ⤷ Subscribe |
| Norketamine | ⤷ Subscribe | Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods | Amorsa Therapeutics, Inc. (Littleton, MA) | ⤷ Subscribe |
| Norketamine | ⤷ Subscribe | Assay for methoxetamine | Randox Laboratories Ltd. (GB) | ⤷ Subscribe |
| Norketamine | ⤷ Subscribe | Oral dosage forms of ketamine | Develco Pharma Schweiz AG (Pratteln, CH) | ⤷ Subscribe |
| Norketamine | ⤷ Subscribe | Extended release pharmaceutical formulation | Douglas Pharmaceuticals, Ltd. (NZ) | ⤷ Subscribe |
| Norketamine | ⤷ Subscribe | Single layer oral dose of neuro-attenuating ketamine | Amorsa Therapeutics, Inc. (Littleton, MA) | ⤷ Subscribe |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Norketamine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Norketamine | Australia | AU2013328280 | 2032-10-08 | ⤷ Subscribe |
| Norketamine | Brazil | BR112015007647 | 2032-10-08 | ⤷ Subscribe |
| Norketamine | Canada | CA2922340 | 2032-10-08 | ⤷ Subscribe |
| Norketamine | China | CN104837810 | 2032-10-08 | ⤷ Subscribe |
| Norketamine | Eurasian Patent Organization | EA201590697 | 2032-10-08 | ⤷ Subscribe |
| Norketamine | European Patent Office | EP2903963 | 2032-10-08 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
